| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8799157 | The Journal of Arthroplasty | 2018 | 6 Pages |
Abstract
Low-dose IORA was effective in the high-BMI population group, providing tissue concentrations of vancomycin 5-9 times higher than systemic administration. IORA optimizes timing of vancomycin administration and provides high tissue antibiotic concentrations during TKA in this high-risk patient group.
Related Topics
Health Sciences
Medicine and Dentistry
Orthopedics, Sports Medicine and Rehabilitation
Authors
Seung Joon MBChB, Grant A. BSc (Hons), Mei PhD, Henry D. MD, Mark J. MD, Simon W. FRACS, MD,